Naprelan (naproxen sodium) NDC 52427-273

NDC codes

FDA NDC Directory

Product NDC (as listed)52427-273Labeler and product segments. Claims need a package NDC.

Product NDC at billing width52427-0273Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
52427-273-75	52427027375	75 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (52427-273-75)Marketed from Jan 17, 2014

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Naprelan
Generic name (nonproprietary): naproxen sodium
Active ingredients: Naproxen sodium — 500 mg/1
Dosage form: Tablet, Film coated, Extended release
Route: Oral
Labeler: Almatica Pharma LLC
Product type: Prescription drug
Marketing category: NDA — New Drug ApplicationApplication NDA 020353
Marketing start: Jan 17, 2014
Marketing end: Jul 1, 2027
Other FDA classes: Non-Steroidal (Chemical structure)Cyclooxygenase Inhibitors (Mechanism)
Identifiers: Product ID 52427-273_cc98185d-7e2e-eea6-8bbd-08585361b654SPL ID cc98185d-7e2e-eea6-8bbd-08585361b654SPL set ID e633ff0b-eab7-f167-8d08-e9236e54042bRxCUI 1116320, 1116331, 1116339, 1116341, 1116349, 1116351UNII 9TN87S3A3CUPC 0352427272011, 0352427274305, 0352427273759
Pharmacologic class: Nonsteroidal Anti-inflammatory Drug

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N452427027375 followed by a unit qualifier and the quantity

Package 52427-0273-75. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Label details couldn’t be retrieved right now. Open the label on DailyMed.

Other NDCs under NDA 020353

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under NDA 020353
Product	Strength	Form · route	Labeler	Product NDC
Naproxen Sodium	Naproxen sodium 500 mg/1	Tablet, Film coated, Extended releaseOral	Alvogen Inc.	47781-154
Naproxen Sodium	Naproxen sodium 375 mg/1	Tablet, Film coated, Extended releaseOral	Upsher-Smith Laboratories, LLC	24979-252
Naprelannaproxen sodium	Naproxen sodium 375 mg/1	Tablet, Film coated, Extended releaseOral	Upsher-Smith Laboratories, LLC	24979-249
Naprelannaproxen sodium	Naproxen sodium 500 mg/1	Tablet, Film coated, Extended releaseOral	Upsher-Smith Laboratories, LLC	24979-250
Naprelannaproxen sodium	Naproxen sodium 750 mg/1	Tablet, Film coated, Extended releaseOral	Upsher-Smith Laboratories, LLC	24979-251
Naproxen Sodium	Naproxen sodium 500 mg/1	Tablet, Film coated, Extended releaseOral	Upsher-Smith Laboratories, LLC	24979-253
Naproxen Sodium	Naproxen sodium 750 mg/1	Tablet, Film coated, Extended releaseOral	Upsher-Smith Laboratories, LLC	24979-254
Naprelannaproxen sodium	Naproxen sodium 375 mg/1	Tablet, Film coated, Extended releaseOral	Almatica Pharma LLC	52427-272
Naproxen Sodium	Naproxen sodium 375 mg/1	Tablet, Film coated, Extended releaseOral	SA3, LLC	69420-1375
Naproxen Sodium	Naproxen sodium 375 mg/1	Tablet, Film coated, Extended releaseOral	Alvogen Inc.	47781-153